CorMedix, Inc. (CRMD)
7.32
+0.08
(+1.10%)
USD |
NASDAQ |
Apr 13, 16:00
7.31
-0.01
(-0.14%)
After-Hours: 20:00
CorMedix Cash from Investing (TTM) : -308.43M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc. | -1.351B |
| Amicus Therapeutics, Inc. | -46.43M |
| Altimmune, Inc. | -132.47M |
| Insmed, Inc. | -64.58M |
| Theravance Biopharma, Inc. | -105.28M |